Clinical Trial Update: Botox for the Treatment of Overactive Bladder Secondary to Benign Prostatic Obstruction [Phase 3]

View source ↗

Summary

Phase 3 clinical trial of Botox for overactive bladder due to benign prostatic obstruction has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Botox (OnabotulinumtoxinA)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Overactive Bladder | Phase 3 | Status: COMPLETED | Results posted: 2019-02-26